According to new report available with Million Insights, The rapid growth of aging population coupled with significant increase of the disease conditions such as ulcers, osteoarthritis, and dry eyes are the key factors boosting the demand. On the other hand, allergic reactions, other cost effective treatments along with several regulations concerns could act as restraints in the growth of hyaluronic acid solution market.

Global Hyaluronic Acid Solution Market is segmented on the basis of product type, end user, and region. Hyaluronic acid, also known as hyaluronan or HA, is an organic compound which fits the branch of carbohydrates and further to its polysaccharides segment. HA is prepared in laboratory by numerousprocedures which includes extraction from rooster combs, in-vitro, and bacterial production.It is a non-sulfated glycosaminoglycan which is present in the connective, epithelial, and neural tissues of living organisms. Due to its hydrophilic nature, hyaluronic acid is used as a shock absorber and lubricant in various joint disorders, including osteoarthritis. The rapid growth of aging population coupled with significant increase of the disease conditions such as ulcers, osteoarthritis, and dry eyes are the key factors boosting the demand. On the other hand, allergic reactions, other cost effective treatments along with several regulations concerns could act as restraints in the growth of hyaluronic acid solution market.

Hyaluronic Acid Solution Market is classified, by product type into Single Injection, Three Injection, and Five Injection. Three-injection cycle accounted for the largest market share in 2015 and is expected to gain popularity over the forecast period. The dose is injected into synovial fluid of knee and hip to ease movement and improve joint pain. These doses are taken in the span of 3 to 5 weeks depending on the condition and severity of the disease.Single injection cycle is expected to be the fastest growing segment with a highest. This is accredited to the preference of patients to short duration of treatment and quick results. In 2016, Genzyme Corporation received the FDA approval for its single injection treatment regimen, Synvisc-One. The product contains high-molecular-weight polymers that act as a lubricant and reduce pain due to osteoarthritis.

Hyaluronic Acid Solution Market is classified, by applications into Osteoarthritis, Opthalmic, Dermal Fillers, and Vesicoureteral Reflux. Dermal fillers accounted for the largest market share of the Hyaluronic Acid Solution Market and are expected to lead the market over forecast period. Vesicoureteral Reflux segment is expected to grow at the highest CAGR over the forecast period. This is due to the change in lifestyle, injuries, and increased rate of surgeries performed. Endoscopic treatment with HA injection is gaining popularity as a treatment option.Opthalmology market segment is expected to witness increasing demand over the forecast period. This is mainly due to the increasing incidence of diseases such as cataracts, glaucoma, age-related macular degeneration and dry eyes. There are more than 0.2 million opthalmologists globally. Moreover, the occurrence of dry eyes is very high in the U.S. with 40 million people suffering from it. This provides a huge opportunity for expansion of ophthalmology related applications of HA products.

Hyaluronic Acid Solution Market is classified, by raw materials into Grade (Pharmaceutical, Cosmetic & Food, and Orthopedic), Source (Animal Based, Non-Animal Based). Pharmaceutical grade hyaluronic acid segment accounted for the largest market share of the global market and is expected to lead the market over forecast period. Whereas, cosmetic grade hyaluronan is expected to grow at fastest pace over the forecast period. Hyaluronic acid, due to its strong water retention properties, has become an integral part of cosmetics and skin care products.

Non-animal based hyaluronic acid market lead the Hyaluronic Acid Solution Market in 2015. Conventionally, hyaluronan was extracted from rooster combs, but issues such as lack of standardization of the process and opposition from communities fighting for animal cruelty created a need to develop techniques to manufacture it artificially. Hyaluronic Acid Solution Market is segmented, geographically into North America, Europe (Eastern Europe, Western Europe), Asia Pacific, Latin America, Middle East and Africa.

North America accounted for the largest market share of the Hyaluronic Acid Solution Industry in terms of revenue and is expected to remain dominant over the forecast period. The U.S. is the most important market and accounts for majority share of the North America. The population in this region is more conscious about aging and is open to adopt new treatment methods.Asia Pacific is expected to develop as the fastest growing region over the forecast period. Japan is one of the highest contributors to the Asia Pacific revenue, due to its large geriatric population and growing awareness amongst people about aesthetics. Hyaluronic Acid Solution Industry key players are, Allergan, Anika Therapeutics, Sanofi (Genzyme), Salix Pharmaceuticals, Dentsply International, Seikagaku Corporation, F. Hoffmann-La Roche, GaldermaS.A, Zimmer Holdings, Smith & Nephew Plc and Ferring Pharmaceuticals.

About Million InsightsMillion Insights, is a distributor of market research reports, published by premium publishers only. We have a comprehensive market place that will enable you to compare data points, before you make a purchase. Enabling informed buying is our motto and we strive hard to ensure that our clients get to browse through multiple samples, prior to an investment. Service flexibility & the fastest response time are two pillars, on which our business model is founded. Our market research report store, includes in-depth reports, from across various industry verticals, such as healthcare, technology, chemicals, food & beverages, consumer goods, material science & automotive.